Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
AKRO | Akero Therapeutics, Inc. | Chief Development Officer | $2.42M | -$2.93M | -54.8% | Oct 30, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|